A Novel Parameter LIT/N That Predicts Survival in COVID-19 ICU Patients

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 30, 2021

Primary Completion Date

May 7, 2021

Study Completion Date

September 1, 2021

Conditions
COVID-19 Pneumonia
Interventions
DIAGNOSTIC_TEST

the LIT test

The retained functional capacity of leukocytes (primarily neutrophils) to produce ROS in response to PMA in whole blood samples could provide a rapid 10-minute detection method for objectively determining onset or occurrence of severe COVID-19 and monitoring progression and treatment of COVID-19.

Trial Locations (1)

06500

Gazi University, Ankara

All Listed Sponsors
collaborator

Oxford MediStress

UNKNOWN

lead

Gazi University

OTHER

NCT05520918 - A Novel Parameter LIT/N That Predicts Survival in COVID-19 ICU Patients | Biotech Hunter | Biotech Hunter